Research Paper“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine (cas 136232-82-1) use in a time of treatment expansion

Add time:09/03/2019    Source:sciencedirect.com

Backgroundbuprenorphine (cas 136232-82-1) maintenance therapy (BMT) has been widely recognized as one of the most effective treatments for opioid use disorders (OUD). In the midst of the U.S. opioid overdose crisis, local, state, and federal authorities have attempted to increase the availability of BMT, yet few individuals meeting the criteria for OUD utilize BMT. Moreover, recent research suggests that a significant proportion of individuals who use opioids seek out buprenorphine on the illicit market to self-govern and manage withdrawal sickness.

We also recommend Trading Suppliers and Manufacturers of buprenorphine (cas 136232-82-1). Pls Click Website Link as below: cas 136232-82-1 suppliers

Prev:Evaluation of an emergency department buprenorphine (cas 136232-82-1) induction and medication-assisted treatment referral program
Next:Review articleTransdermal buprenorphine (cas 136232-82-1) patch: Potential for role in management of opioid dependence)